Eficacia de la procaina en el tratamiennto de la parálisis facial debido a Herpes Zoster
No hay miniatura disponible
Fecha
2020-11
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil
Resumen
El virus herpes simple pertenece a la familia Herpesviridae. Se encuentra distribuido de forma amplia en los seres humanos con una afectación estimada del 67% a nivel mundial en grupos de edades que no superan los 50 años, se presenta mayoritariamente en dos subgrupos poblacionales, niños que han presentado varicela zóster y adultos que han entrado en contacto con la infección. El Objetivo de este estudio fue demostrar es la eficacia de la procaína en la parálisis facial debido a Herpe Zoster. Se utilizó un enfoque cuantitativo, descriptivo, restrospectivo, en el cual se abordó una muestra de 78 pacientes atendidos en el Centro de Atención y tratamientos médicos Quito, los cuales presentaron diagnóstico de herpes zoster y parálisis facial debido al virus. Resultados de los 78 pacientes con diagnóstico de herpes y parálisis facial, 40 personas pertenecieron al sexo masculino y 38 femeninos con un rango de edades entre 31 a mayores de 41 años. La aplicación de procaina demostró que el 86,8% de hombres y 86,20% de las mujeres lograron eliminar la Paralisis facial. experimentando una disminución parcial de la paralisis facial en un 3,4%. Se concluyó que el uso de procaina demostró efectividad para el tratamiento de la Paralisis facial debido por herpes zoster, situación ante la cual se recomienda el uso de dicho tratamiento como alternativa de abordaje a la condición descrita.
The herpes simplex virus belongs to the Herpesviridae family. It is widely distributed in humans with an estimated 67% worldwide involvement in age groups that do not exceed 50 years. The objective of this study was to demonstrate the efficacy of procaine in facial paralysis due to Herpe Zoster. A quantitative, descriptive, retrospective approach was used, in which a sample of 78 patients treated at the Quito Medical Care and Treatment Center was approached, who presented a diagnosis of herpes zoster and facial paralysis due to the virus. Results of the 78 patients diagnosed with herpes and facial paralysis, 40 people belonged to males and 38 to females, with an age range from 31 to over 41 years. The application of procinamide showed that 86.8% of men and 86.20% of women were able to completely eliminate pain, experiencing a partial decrease in pain of 3.4%. It was concluded that the use of procainamide demonstrated effectiveness for the therapy of pain caused by herpes zoster, a situation in which the use of such treatment is recommended as an alternative approach to the condition described.
The herpes simplex virus belongs to the Herpesviridae family. It is widely distributed in humans with an estimated 67% worldwide involvement in age groups that do not exceed 50 years. The objective of this study was to demonstrate the efficacy of procaine in facial paralysis due to Herpe Zoster. A quantitative, descriptive, retrospective approach was used, in which a sample of 78 patients treated at the Quito Medical Care and Treatment Center was approached, who presented a diagnosis of herpes zoster and facial paralysis due to the virus. Results of the 78 patients diagnosed with herpes and facial paralysis, 40 people belonged to males and 38 to females, with an age range from 31 to over 41 years. The application of procinamide showed that 86.8% of men and 86.20% of women were able to completely eliminate pain, experiencing a partial decrease in pain of 3.4%. It was concluded that the use of procainamide demonstrated effectiveness for the therapy of pain caused by herpes zoster, a situation in which the use of such treatment is recommended as an alternative approach to the condition described.
Descripción
Palabras clave
HERPES ZÓSTER, TRATAMIENTO, PROCAÍNA, PARÁLISIS
Citación
APA